Vitamin D Levels in Women With Polycystic Ovary Syndrome

Ghamra Military Hospital

Status and phase: Completed; Phase 4

Conditions: Polycystic Ovary Syndrome

Treatments: Drug: Vitamin D Levels measurement using chemiluminescent assay; Device: Vitamin D level assessment

Study type: Interventional

Funder types: Other

Identifiers

NCT05101811

GhamraMH

Details and patient eligibility

About

Polycystic ovary syndrome is the commonest endocrinopathy among women of reproductive age. Its worldwide prevalence has been estimated between5-10%.

Vitamin D, a fat-soluble vitamin, can be produced in two ways: by intestinal absorption and endogenous synthesis from a precursor of 17-hydroxyl cholesterol on the skin with sufficient exposure to ultraviolet sunlight.

Full description

The aim of this work is assessment of the level of vitamin D in female have polycystic ovary syndrome & healthy female.and also make diagnostic criteria for patient who is in need for supplementations with vitamin D.

Enrollment: 90 patients

Sex: Female

Ages: 18 to 35 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Hyperandrogenism
• Polycystic ovary syndrome

Exclusion criteria

• Thyroid disease
• Parathyroid disease
• Diabetes Mellitus
• Cushing syndrome
• Congenital adrenal hyperplasia
• Hyperprolactinemia
• Renal, liver or chronic disease

Trial design

Primary purpose: Diagnostic

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

90 participants in 2 patient groups

Control women without polycystic ovary syndrome

Experimental group

Description:

Normal fertile women without polycystic ovary syndrome

Treatment:

Device: Vitamin D level assessment

Drug: Vitamin D Levels measurement using chemiluminescent assay

Case women with polycystic ovary syndrome

Experimental group

Description:

Women with polycystic ovary syndrome

Treatment:

Device: Vitamin D level assessment

Drug: Vitamin D Levels measurement using chemiluminescent assay